Free Trial

DexCom (DXCM) SEC Filings & 10K Form

DexCom logo
$84.78 -0.55 (-0.64%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$84.76 -0.02 (-0.02%)
As of 07/15/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent DexCom SEC Filings

DateFilerForm TypeView
07/07/2025
3:15 PM
DexCom (Issuer)
GALA RENEE D (Reporting)
Form 4/A
06/30/2025
5:47 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:31 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:31 PM
DexCom (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
4:33 PM
AUGUSTINOS NICHOLAS (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
2:59 PM
AUGUSTINOS NICHOLAS (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2025
3:35 PM
DexCom (Filer)
Form SD
Specialized Disclosure Report  
05/28/2025
3:50 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
3:51 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
3:18 PM
DexCom (Subject)
Stern Sadie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
7:31 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2025
3:18 PM
DexCom (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2025
3:20 PM
DexCom (Filer)
Form 8-K/A
05/02/2025
3:15 PM
DexCom (Filer)
Form DEFA14A
05/01/2025
4:15 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2025
8:20 AM
BlackRock, Inc. (Filed by)
DexCom (Subject)
Form SCHEDULE 13G/A
03/31/2025
5:57 PM
Coleman Jon (Reporting)
DexCom (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2025
8:01 AM
DexCom (Filer)
Form DEF 14A
03/27/2025
8:02 AM
DexCom (Filer)
Form DEFA14A
03/27/2025
8:04 AM
DexCom (Filer)
Form ARS
03/25/2025
3:30 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
4:02 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
8:40 AM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
4:24 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:25 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:25 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:25 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:25 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:17 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:17 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:17 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:17 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:17 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:01 PM
DexCom (Issuer)
GALA RENEE D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
3:46 PM
DexCom (Issuer)
GALA RENEE D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
7:31 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:31 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
3:30 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2025
5:06 AM
DexCom (Filer)
Form S-3ASR
01/30/2025
5:43 PM
DexCom (Issuer)
SAYER KEVIN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
I warned you about Nvidia… now look what’s happening (Ad)

Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.

Watch how Tim Sykes trades AI headlines for real gains
01/30/2025
5:44 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Dolan Matthew Vincent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:44 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:31 AM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
3:05 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
3:15 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
10:56 AM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:15 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
4:13 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:04 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
3:17 PM
DexCom (Issuer)
Heller Bridgette P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
8:53 AM
DexCom (Subject)
Heller Bridgette P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
6:05 PM
DexCom (Issuer)
Leach Jacob Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:05 PM
DexCom (Issuer)
Sylvain Jereme M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:05 PM
DexCom (Issuer)
Stern Sadie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:22 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:23 PM
Brown Michael Jon (Reporting)
DexCom (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:04 PM
Brown Michael Jon (Reporting)
DexCom (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
4:18 PM
DexCom (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
3:05 PM
DexCom (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DXCM) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners